|
1
|
Peng Z, Wang S, Chen G, Cai M, Liu R, Deng
J, Liu J, Zhang T, Tan Q and Hai C: Gastrodin alleviates cerebral
ischemic damage in mice by improving anti-oxidant and
anti-inflammation activities and inhibiting apoptosis pathway.
Neurochem Res. 40:661–673. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wong SB, Hung WC and Min MY: The role of
gastrodin on hippocampal neurons after N-methyl-D-aspartate
excitotoxicity and experimental temporal lobe seizures. Chin J
Physiol. 59:156–164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang X, Yan S, Wang A, Li Y and Zhang F:
Gastrodin ameliorates memory deficits in
3,3′-iminodipropionitrile-induced rats: Possible involvement of
dopaminergic system. Neurochem Res. 39:1458–1466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kumar H, Kim IS, More SV, Kim BW, Bahk YY
and Choi DK: Gastrodin protects apoptotic dopaminergic neurons in a
toxin-induced Parkinson's disease model. Evid Based Complement
Alternat Med. 2013:5140952013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Viguier F, Michot B, Hamon M and Bourgoin
S: Multiple roles of serotonin in pain control mechanisms -
implications of 5-HT(7) and other 5-HT receptor types. Eur J
Pharmacol. 716:8–16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lv QQ, Wu WJ, Guo XL, Liu RL, Yang YP,
Zhou DS, Zhang JX and Liu JY: Antidepressant activity of astilbin:
Involvement of monoaminergic neurotransmitters and BDNF signal
pathway. Biol Pharm Bull. 37:987–995. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ignjatovic Bugarski V, Semnic M, Bukurov
Gebauer K and Kozic D: Cognitive impairment and functional ability
in the acute phase of ischemic stroke. Eur Rev Med Pharmacol Sci.
19:3251–3256. 2015.
|
|
8
|
Gaete JM and Bogousslavsky J: Post-stroke
depression. Expert Rev Neurother. 8:75–92. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kauhanen M, Korpelainen JT, Hiltunen P,
Brusin E, Mononen H, Määttä R, Nieminen P, Sotaniemi KA and Myllylä
VV: Poststroke depression correlates with cognitive impairment and
neurological deficits. Stroke. 30:1875–1880. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
De Ryck A, Brouns R, Geurden M, Elseviers
M, De Deyn PP and Engelborghs S: Risk factors for poststroke
depression: Identification of inconsistencies based on a systematic
review. J Geriatr Psychiatry Neurol. 27:147–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Robinson RG, Starr LB and Price TR: A two
year longitudinal study of mood disorders following stroke.
Prevalence and duration at six months follow-up. Br J Psychiatry.
144:256–262. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Salinas J, Ray RM, Nassir R,
Lakshminarayan K, Dording C, Smoller J, Wassertheil-Smoller S,
Rosand J and Dunn EC: Factors associated with New-Onset depression
following ischemic stroke: The women's health initiative. J Am
Heart Assoc. 6:62017. View Article : Google Scholar
|
|
13
|
Mazure CM, Weinberger AH, Pittman B, Sibon
I and Swendsen J: Gender and stress in predicting depressive
symptoms following stroke. Cerebrovasc Dis. 38:240–246. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang SY, Wang M, Wang XX, Chen W, Sheng C
and Gong ZK: Study on the clinical application of the MRS in the
cognitive assessment after stroke. Eur Rev Med Pharmacol Sci.
21:2437–2442. 2017.PubMed/NCBI
|
|
15
|
Paolucci S: Advances in antidepressants
for treating post-stroke depression. Expert Opin Pharmacother.
18:1011–1017. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Flaster M, Sharma A and Rao M: Poststroke
depression: A review emphasizing the role of prophylactic treatment
and synergy with treatment for motor recovery. Top Stroke Rehabil.
20:139–150. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hammerness P, Basch E, Ulbricht C,
Barrette EP, Foppa I, Basch S, Bent S, Boon H and Ernst E; Natural
Standard Research Collaboration, : St John's wort: A systematic
review of adverse effects and drug interactions for the
consultation psychiatrist. Psychosomatics. 44:271–282. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Larsson E, Nanobashvili A, Kokaia Z and
Lindvall O: Evidence for neuroprotective effects of endogenous
brain-derived neurotrophic factor after global forebrain ischemia
in rats. J Cereb Blood Flow Metab. 19:1220–1228. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Strüder HK and Weicker H: Physiology and
pathophysiology of the serotonergic system and its implications on
mental and physical performance. Part I. Int J Sports Med.
22:467–481. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chhibber A, Woody SK, Rumi Karim MA,
Soares MJ and Zhao L: Estrogen receptor β deficiency impairs
BDNF-5-HT2A signaling in the hippocampus of female brain: A
possible mechanism for menopausal depression.
Psychoneuroendocrinology. 82:107–116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee J, Duan W and Mattson MP: Evidence
that brain-derived neurotrophic factor is required for basal
neurogenesis and mediates, in part, the enhancement of neurogenesis
by dietary restriction in the hippocampus of adult mice. J
Neurochem. 82:1367–1375. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gaspar P, Cases O and Maroteaux L: The
developmental role of serotonin: News from mouse molecular
genetics. Nat Rev Neurosci. 4:1002–1012. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Santarelli L, Saxe M, Gross C, Surget A,
Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, et
al: Requirement of hippocampal neurogenesis for the behavioral
effects of antidepressants. Science. 301:805–809. 2003. View Article : Google Scholar : PubMed/NCBI
|
